States file third suit against generics industry
A coalition of 51 US states and territories have filed their third sweeping antitrust lawsuit against the generic pharmaceuticals industry, alleging a massive conspiracy to fix prices for topical skin treatments.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10